Related Experiment Videos
Ventricular fibrillation: new insights into mechanisms
James N Weiss1, Peng-Sheng Chen, Tsu-Juey Wu
1David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA. jweiss@mednet.ucla.edu
Annals of the New York Academy of Sciences
|June 18, 2004
Summary
Implantable cardioverter-defibrillators are effective against sudden cardiac death but costly. New insights into ventricular fibrillation mechanisms offer promising, cost-effective alternative therapies to prevent sudden cardiac death.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Devices
Background:
- Implantable cardioverter-defibrillators (ICDs) are the sole proven treatment for sudden cardiac death (SCD) from ventricular fibrillation.
- Expanding ICD indications present significant economic challenges to healthcare systems.
- There is a critical need for alternative, cost-effective therapies to prevent SCD.
Purpose of the Study:
- To explore novel therapeutic strategies for preventing sudden cardiac death.
- To investigate the underlying mechanisms of ventricular fibrillation.
- To identify new avenues for device-free SCD prevention.
Main Methods:
- Review of current literature on device therapy for SCD.
- Analysis of recent research on ventricular fibrillation dynamics.
- Exploration of emerging therapeutic targets based on wave instability mechanisms.
Main Results:
- Current device therapy, while effective, is associated with high healthcare costs.
- Understanding dynamic factors in ventricular fibrillation, such as wave instability, is crucial.
- These insights pave the way for developing non-device-based interventions.
Conclusions:
- Novel therapies targeting ventricular fibrillation mechanisms are needed.
- Developing alternative strategies can reduce healthcare burden.
- Further research into dynamic wave instability holds promise for SCD prevention.